Novel Mechanism Regulating RAS Activity in the Brain: Role in Neurogenic Hypertension
调节大脑 RAS 活性的新机制:在神经源性高血压中的作用
基本信息
- 批准号:10213809
- 负责人:
- 金额:$ 47.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAngiotensin IIAngiotensinogenBloodBlood PressureBrainBudgetsCRISPR/Cas technologyCardiovascular systemCell LineCell NucleusCellsDOCADataDisinhibitionEnergy MetabolismExhibitsExonsExperimental Water DeprivationExposure toFutureGenerationsGenesGeneticGenetic TranscriptionHigh Fat DietHomeostasisHypertensionHypothalamic structureImpairmentIn VitroInactive ReninIntakeKidneyLightLiquid substanceMediatingMessenger RNAMetabolicMethodsModelingMolecularMusNerveNeurogliaNeuronsPathologicPeptide Signal SequencesPhysiologicalPlayPreventionProductionProsencephalonProtein IsoformsRegulationReninRenin-Angiotensin SystemReporterRoleSeminalSignal TransductionSiteSodium ChlorideStimulusStructure of nucleus infundibularis hypothalamiSubfornical OrganSympathetic Nervous SystemSystemTestingUpstream Enhancerdietaryextracellulargenetic manipulationgenome editinginhibitor/antagonistinnovationmouse modelneuroblastoma cellneurogenic hypertensionnovelparaventricular nucleuspreservationpromoterreceptorresponsestressorsynergism
项目摘要
Summary/Abstract
The brain renin-angiotensin system (RAS) plays a crucial role in regulating cardiovascular and metabolic
function. Nuclei-specific synthesis and action of angiotensin-II (ANG) in the brain affords mechanisms for the
independent regulation of fluid intake and sympathetic nerve activity (SNA) controlling blood pressure (BP) and
metabolic responses. That angiotensinogen (AGT), the substrate for renin and precursor to ANG is
constitutively released from glial cells throughout the brain, and from neurons in nuclei controlling
cardiovascular and metabolic function, implores the central question of how ANG production in the brain is
regulated? We identified an unexpected and novel mechanism regulating expression of renin in the brain
which may address this. However, the initiating signals and mechanisms involved remains unknown. This
project will examine the innovative concepts and hypotheses that: 1) there is coordinate regulation of renin
mRNA isoforms which controls RAS activity in the brain, and 2) impairment of this novel control mechanism
causes neurogenic hypertension and increases sensitivity of exposure to hypertension-causing stimuli. We will
examine this original concept in the following two specific aims: 1) test the hypothesis that coordinated
expression of Ren-b and Ren-a in the subfornical organ (SFO), paraventricular nucleus (PVN), and arcuate
nucleus (ARC) mediates local ANG production and action which alters SNA controlling cardiovascular and
metabolic function, and 2) test the hypothesis that disinhibition of Ren-a expression with concomitant inhibition
of renin-b expression in the SFO, PVN and ARC is required to mediate sensitization of the hypertensive
response (HTR) to mild humoral (e.g. ANG) and dietary (e.g. high fat diet) stressors. The studies will advance
the concepts that a) Ren-b expression is an endogenous inhibitor of Ren-a expression limiting ANG production
in the presence of excess extracellular AGT, and b) under conditions which threaten homeostasis (e.g. water
deprivation) or in response to pathological stimuli (e.g. DOCA-salt or high fat diet), previously dormant Ren-a
expression is disinhibited leading to site-specific prorenin activation, ANG generation and ANG action.
Importantly, we hypothesize that impairment of this regulatory circuit causes neurogenic hypertension. The
project has natural synergy as other projects that will similarly examine blood pressure and metabolic signaling
in forebrain and hypothalamic nuclei. Moreover, this project will be informed by the data collected by the other
projects and will synergize by exploring RAS-dependent and renin-dependent mechanisms in those systems.
摘要/摘要
脑肾素 - 血管紧张素系统(RAS)在调节心血管和代谢中起着至关重要的作用
功能。血管紧张素-II(ANG)在大脑中的核特异性合成和作用提供了机制
独立调节液体摄入液和交感神经活动(SNA)控制血压(BP)和
代谢反应。那个血管紧张素原(AGT),肾素和ANG前体的底物为
从整个大脑中的神经胶质细胞和核控制中的神经元的组成性释放
心血管和代谢功能,涉及大脑中ANG的产生方式的核心问题
受监管?我们确定了一种意外的新型机制,用于调节肾素在大脑中的表达
这可以解决这个问题。但是,涉及的启动信号和机制仍然未知。这
项目将研究以下创新概念和假设:1)肾素有协调调节
控制大脑中RAS活性的mRNA同工型,以及2)这种新型控制机制的损害
引起神经源性高血压并增加暴露于引起高血压刺激的敏感性。我们将
在以下两个具体目的中检查这个原始概念:1)检验协调的假设
Ren-B和Ren-A在副脱机器官(SFO),室室核(PVN)和弧形中的表达
核(ARC)介导了局部ANG的产生和作用,从而改变了控制心血管和
代谢功能,以及2)检验以下假设:抑制Ren-A表达与抑制作用
SFO,PVN和ARC中的肾素-B表达需要介导高血压的敏化
对轻度体液(例如ANG)和饮食(例如高脂饮食)压力的反应(HTR)。研究将进步
a)ren-b表达是ren-a表达限制ANG产生的内源性抑制剂的概念
在存在过多的细胞外AGT的情况下,b)在威胁稳态的条件下(例如水
剥夺)或应对病理刺激(例如Doca-盐或高脂饮食),以前是休眠的REN-A
表达被抑制导致特异性特异性prorenin激活,ANG的产生和ANG作用。
重要的是,我们假设该调节回路的损害会导致神经源性高血压。这
项目具有自然协同作用,因为其他项目将同样检查血压和代谢信号传导
在前脑和下丘脑核中。此外,该项目将由另一个项目收集的数据告知
项目并将通过探索这些系统中的RAS依赖性和肾素依赖性机制来协同作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Curt Daniel Sigmund其他文献
Curt Daniel Sigmund的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Curt Daniel Sigmund', 18)}}的其他基金
PPARG-dependent Mechanisms Control Endothelial-Smooth Muscle Coordination, Arterial Pressure, Vasomotor Function and Arterial Stiffness
PPARG 依赖性机制控制内皮-平滑肌协调、动脉压、血管舒缩功能和动脉僵硬度
- 批准号:
10337230 - 财政年份:2019
- 资助金额:
$ 47.7万 - 项目类别:
PPARG-dependent Mechanisms Control Endothelial-Smooth Muscle Coordination, Arterial Pressure, Vasomotor Function and Arterial Stiffness
PPARG 依赖性机制控制内皮-平滑肌协调、动脉压、血管舒缩功能和动脉僵硬度
- 批准号:
10092211 - 财政年份:2019
- 资助金额:
$ 47.7万 - 项目类别:
PPARG-dependent Mechanisms Control Endothelial-Smooth Muscle Coordination, Arterial Pressure, Vasomotor Function and Arterial Stiffness
PPARG 依赖性机制控制内皮-平滑肌协调、动脉压、血管舒缩功能和动脉僵硬度
- 批准号:
10565914 - 财政年份:2019
- 资助金额:
$ 47.7万 - 项目类别:
PPG-Genetic and Signaling Mechanisms in the Central Regulation of Blood Pressure
PPG-血压中枢调节的遗传和信号机制
- 批准号:
9278663 - 财政年份:2016
- 资助金额:
$ 47.7万 - 项目类别:
Role of PPARG the PPARG Target Gene RBP7 in the Endothelium
PPARG 的作用 PPARG 靶基因 RBP7 在内皮细胞中的作用
- 批准号:
9249635 - 财政年份:2016
- 资助金额:
$ 47.7万 - 项目类别:
Hypertension: Role of Smooth Muscle Cullin-3 and the CRL3 Complex
高血压:平滑肌 Cullin-3 和 CRL3 复合体的作用
- 批准号:
8956718 - 财政年份:2015
- 资助金额:
$ 47.7万 - 项目类别:
PPG-Genetic and Signaling Mechanisms in the Central Regulation of Blood Pressure
PPG-血压中枢调节的遗传和信号机制
- 批准号:
7433915 - 财政年份:2007
- 资助金额:
$ 47.7万 - 项目类别:
Novel Mechanism Regulating RAS Activity in the Brain: Role in Neurogenic Hypertension
调节大脑 RAS 活性的新机制:在神经源性高血压中的作用
- 批准号:
10445017 - 财政年份:2007
- 资助金额:
$ 47.7万 - 项目类别:
相似国自然基金
等位基因聚合网络模型的构建及其在叶片茸毛发育中的应用
- 批准号:32370714
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于等位基因非平衡表达的鹅掌楸属生长量杂种优势机理研究
- 批准号:32371910
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于人诱导多能干细胞技术研究突变等位基因特异性敲除治疗1型和2型长QT综合征
- 批准号:82300353
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACR11A不同等位基因调控番茄低温胁迫的机理解析
- 批准号:32302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠杆菌多粘菌素异质性耐药中phoPQ等位基因差异介导不同亚群共存的机制研究
- 批准号:82302575
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm
血管平滑肌细胞铁死亡与腹主动脉瘤
- 批准号:
10733477 - 财政年份:2023
- 资助金额:
$ 47.7万 - 项目类别:
Uncovering the role of GPR75 as an activator of fatty acid transporters in non-alcoholic fatty liver disease (NAFLD)
揭示 GPR75 作为脂肪酸转运蛋白激活剂在非酒精性脂肪性肝病 (NAFLD) 中的作用
- 批准号:
10666762 - 财政年份:2023
- 资助金额:
$ 47.7万 - 项目类别:
Mechanisms of myeloperoxidase and Nox4 interactions in abdominal aortic aneurysm
腹主动脉瘤中髓过氧化物酶和 Nox4 相互作用的机制
- 批准号:
9924277 - 财政年份:2018
- 资助金额:
$ 47.7万 - 项目类别:
Non-Coding Variants of Angiotensinogen Gene and Hypertension
血管紧张素原基因的非编码变异与高血压
- 批准号:
9197334 - 财政年份:2016
- 资助金额:
$ 47.7万 - 项目类别:
Non-Coding Variants of Angiotensinogen Gene and Hypertension
血管紧张素原基因的非编码变异与高血压
- 批准号:
9325162 - 财政年份:2016
- 资助金额:
$ 47.7万 - 项目类别: